Amplicon-seq™
Confirmation assay
SeQure DX's Amplicon-seq assay provides high-sensitivity confirmation of on- and off-target edits in gene-edited cell lines and tissues. Targeted amplicon sequencing is guided by the results of ONE-seq, DEUX-seq and GUIDE-seq, enabling precise validation of gene editing outcomes in your cells of interest. By delivering detailed and accurate editing confirmation, Amplicon-seq supports regulatory expectations, reduces risks of IND filing delays, and strengthens the safety profile of your cell and gene therapy development programs.
Amplicon-seq overview
Amplicon-seq
High-sensitivity confirmation of off-targets in your cell type of interest post-editing. Informed by our nomination assays, we know exactly where we need to look to confirm editing.
Confirmation
Verifies cellular edits
- Sensitive detection methods
- Relevant cell types
- On- and off-target analysis
Cellular editing assessment
IND filings
- Biologic impact assessment
- GLP
Related confirmation assays
Learn more about our comprehensive suite of assays spanning from early discovery through pre-clinical and clinical development.
